Skip to main content

stock

IMMX · Immix Biopharma, Inc.

What Immix Biopharma, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live IMMX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on IMMX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
71,539,314 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-17.4%
ROA
-16.7%

Health

Current ratio
25.1x
Debt/equity
—

Deep value

NCAV
$223.60M
NCAV per share
$3.13
Price/NCAV
Locked
NNWC
$215.30M
NNWC per share
$3.01
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$12.46M-$11.56M
10-Q filed 2026-08-07
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$10.80M-$10.09M
10-Q filed 2026-08-07
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$10.89M-$10.65M
10-Q filed 2026-08-07
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$7.66M-$7.59M
10-Q filed 2025-11-07
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$6.72M-$6.62M
10-Q filed 2026-08-07
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$4.68M-$4.54M
10-Q filed 2026-08-07
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$4.99M-$4.81M
10-K/A filed 2026-03-27
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$7.39M-$7.15M
10-Q filed 2025-11-07
Assets
$239.11M
Equity
$228.92M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$29.96M-$29.40M-$24.66M
2024-12-31—-$22.67M-$21.61M-$15.77M
2023-12-31—-$16.14M-$15.43M-$11.42M
2022-12-31—-$8.22M-$8.23M—
2021-12-31—-$1.35M-$24.38M-$1.59M
2020-12-31—-$453,852-$1.15M—

Company filings

since Fri Jan 9 · 4 offering filings in 12 months · since Tue Sep 29

events

  • Other event

    Other event
    Sep 308-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Sep 298-K
  • Other event

    Other event
    Jul 208-K
  • Shareholder vote results

    Shareholder vote results
    May 298-K
  • Other event

    Other event
    May 218-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    May 218-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named IMMX, and the market events around them.

Sign in to see this

Board

The IMMX board could not be loaded.

Retry the IMMX board

nakagai

Signals on IMMX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the IMMX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Immix Biopharma, Inc. (IMMX): SEC filings, financials and insider trades · Nakagai